Zhejiang Haisen Pharmaceutical (001367) Stock Overview

Zhejiang Haisen Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical raw materials and intermediates in China. The company offers APIs for digestive system, antipyretic analgesic, and cardiovascular drugs, as well as antidepressants and anti-bacterials. It is also developing APIs for antiviral and non-steroidal anti-inflammatory drugs. The company was founded in 1998 and is based in Dongyang, China.